Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness.
Tischkowitz
M
M
Gologan
A
A
Srolovitz
H
H
Khanna
M
M
Foulkes
W D
WD
D001005:Anus Neoplasms / Q000235:genetics*; D024682:BRCA2 Protein / Q000235:genetics; D002294:Carcinoma, Squamous Cell / Q000235:genetics*; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D007636:Keratoacanthoma / Q000235:genetics; D008297:Male; D051718:MutS Homolog 2 Protein / Q000235:genetics*; D009154:Mutation; D009378:Neoplasms, Multiple Primary / Q000235:genetics*; D016609:Neoplasms, Second Primary / Q000235:genetics*; D012626:Sebaceous Gland Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D012878:Skin Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D013577:Syndrome
D024682:BRCA2 Protein; C497172:MSH2 protein, human; D051718:MutS Homolog 2 Protein